Stocks · Market intelligence desk
Market open

MAXHEALTH MAX HEALTHCARE INS LTD

OverviewPrice & levelsF&OFinancials & peersCompanyas of Thu 15 Oct 15:30

MAX HEALTHCARE INS LTD — on this desk since 29 Nov 2024.

revenue, Apr–Jun 2026
₹2,366 crore
17% above a year earlier
profit, same quarter
₹323 crore
5% above a year earlier
revenue, four quarters
₹8,712 crore
16% above the four before
conditions held
9 of 9
of those measured

Its own figures

as of Thu 13 Aug 15:41

MAX HEALTHCARE INS LTD filed Apr–Jun 2026 on Thu 13 Aug 2026, read on its consolidated figures (the group).

Revenue was ₹2,366 crore, 17% above a year earlier; profit was ₹323 crore, 5% above a year earlier.

Over four quarters it kept 17 of every 100 rupees of revenue as profit.

Its borrowings were 32 in every 100 of its equity at 31 Mar 2026.

Sources
  • Integrated Filing (Financials) with NSE, as XBRL, reached the market Thu 13 Aug 2026 · SHA-256 406f2e19c54a · raw/nse_integrated_filing/2026-06-30/406f2e19c54a_INTEGRATED_FILING_INDAS_1713411_13082026034155_WEB.xml

Nine conditions, each measured

as of Thu 13 Aug 15:41

9 of the 9 conditions that could be measured held.

  • Held: revenue over the last four quarters was above the four before.
  • Held: profit over the last four quarters was above the four before.
  • Held: profit over the last four quarters was above zero.
  • Held: the operating margin over the last four quarters held against the four before.
  • Held: cash from operations was at least 80 in every 100 of profit, latest full year.
  • Held: borrowings were no more than equity.
  • Held: profit before interest covered interest at least three times.
  • Held: promoters had pledged at most 5 in every 100 of their shares.
  • Held: promoters' holding did not fall more than one point in a year.

Against its industry

as of Thu 13 Aug 15:41

Healthcare, 20 other companies read for this quarter; revenue over four quarters 16% above the four before, against 14% above the four before for the typical company in the group; it kept 17 of every 100 rupees of revenue as profit, the typical company 12.

The group is its industry as NSE lists it today; each company is read on the quarter it had filed by then, and the company is left out of its own group.

Who holds it

as of Fri 17 Jul 22:23

At 30 Jun 2026: promoters held 24 in every 100 shares, foreign investors 42 in every 100, Indian institutions 30 in every 100 (mutual funds 19 in every 100).

Promoters had pledged 0 in every 100 of their shares.

Show the recordHide the record

The last eight quarters

as of Thu 13 Aug 15:41
quarterreached the marketrevenueagainst a year earlierprofitagainst a year earlier
Apr–Jun 202613 Aug 2026₹2,366 crore17% above₹323 crore5% above
Jan–Mar 202621 May 2026₹2,143 crore12% above₹342 crore7% above
Oct–Dec 20255 Feb 2026₹2,068 crore11% above₹301 crore26% above
Jul–Sep 202514 Nov 2025₹2,135 crore25% above₹491 crore74% above
Apr–Jun 202513 Aug 2025₹2,028 crore31% above₹308 crore30% above
Jan–Mar 202520 May 2025₹1,910 crore34% above₹319 crore27% above
Oct–Dec 202430 Jan 2025₹1,868 crore40% above₹239 crore17% below
Jul–Sep 20245 Nov 2024₹1,707 crore25% above₹282 crore—

Results days

as of Thu 13 Aug 15:41
  • Apr–Jun 2026. Revenue came in at ₹2,366 crore, 2% below the pace of the four quarters before it. The options priced a move of about 4.5%; the stock moved 0.5% down, less than priced.
  • Jan–Mar 2026. Revenue came in at ₹2,143 crore, 10% below the pace of the four quarters before it. The options priced a move of about 3.4%; the stock moved 6.2% down, more than priced.
  • Oct–Dec 2025. Revenue came in at ₹2,068 crore, 16% below the pace of the four quarters before it. The options priced a move of about 5.4%; the stock moved 0.1% down, less than priced.
  • Jul–Sep 2025. Revenue came in at ₹2,135 crore, 6% below the pace of the four quarters before it. The options priced a move of about 4.9%; the stock moved 1.7% up, less than priced.
  • Apr–Jun 2025. Revenue came in at ₹2,028 crore, 1% above the pace of the four quarters before it. The options priced a move of about 4.8%; the stock moved 3.7% down, less than priced.
  • Jan–Mar 2025. Revenue came in at ₹1,910 crore, 7% above the pace of the four quarters before it. The options priced a move of about 5.3%; the stock moved 1.9% down, less than priced.
  • Oct–Dec 2024. Revenue came in at ₹1,868 crore, 17% above the pace of the four quarters before it. The options priced a move of about 12.3%; the stock moved 1.7% up, less than priced.
  • Jul–Sep 2024. Revenue came in at ₹1,707 crore, 6% above the pace of the four quarters before it. No option prices on the eve, or no session after it.

On 1 of 7 results days read here, the stock moved more than its options had priced.